Description

Mirsaeidi et al developed a score for predicting mortality for patients with ventilator-associated pneumonia (VAP). This can help to identify patients who may benefit from more aggressive management. The authors are from the IMPACT-HAP Investigators (Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia).


Patient selection: presence of ventilator-associated pneumonia

 

Parameters (5):

(I) for immunodeficiency

(B) for blood pressure

(M) for multilobular pulmonary infiltrate

(P) for platelet count

(10) for duration of hospitalization > 10 days before onset of VAP

 

Parameter

Finding

Points

immunodeficiency

absent

0

 

present

1

blood pressure

systolic >= 90 mm Hg AND diastolic >= 60 mm Hg

0

 

systolic < 90 mm Hg OR diastolic < 60 mm Hg

1

pulmonary infiltrate

none or single lobe

0

 

multilobular

1

platelet count

>= 100,000 per µL

0

 

< 100,000 per µL

1

hospital stay before onset of VAP

<= 10 days

0

 

> 10 days

1

 

total score =

= SUM(points for all 5 parameters)

 

Interpretation:

• minimum score: 0

• maximum score: 5

• The higher the score the greater the risk of mortality.

 

Total Score

Mortality Rate

0

2%

1

9%

2

24%

3

50%

4

67%

5

NA

 

Performance:

• The area under the ROC curve was 0.824

• The score performed better than the APACHE II score.


To read more or access our algorithms and calculators, please log in or register.